Analysis of prostate-specific antigen bounce after I125 permanent seed implant for localised prostate cancer

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 102-107

  Mitchell, Darren M ^a   Swindell, Ric ^a   Elliott, Tony ^a   Wylie, James P ^a   Taylor, Cathy M ^a   Logue, John P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bounce; Brachytherapy; Kinetics; Prostate Cancer; PSA

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; FOLLOW UP; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SALVAGE THERAPY;

ADULT; AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 45849091883     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.04.004     Document Type: Article

References (19)

1. Pound C.R., Partin A.W., Eisenberger M.A., Chan D.W., Pearson J.D., and Walsh P.C. Natural history of progression after PSA elevation following radical prostatecetomy. JAMA 281 (1999) 1591-1597
2. American Society for Therapeutic Radiology and Oncology Consensus panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
3. Roach M., Hanks G., Thames H., Schellhammer P., Shiplay W.U., Sokol G.H., et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localised prostate cancer: recommendations of the RTOG ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65 (2006) 965-974
4. Stock R.G., Stone N.N., and Cesaretti J.A. Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications. Int J Radiat Oncol Biol Phys 56 (2003) 448-453
5. Merrick G.S., Butler W.M., Wallner K.E., Galbreath R.W., and Anderson R.L. Prostate-specific antigen spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 54 (2002) 450-456
6. Critz F.A., Williams H.W., Benton J.B., Levinson K., Holladay C.T., and Holliday D.A. Prostate specific antigen bounce after radioactive seed implantation followed by external beam radiation for prostate cancer. J Urol 163 (2000) 1085-1089
7. Crook J., Gillan C., Yeung I., Austen L., Mclean M., and Lockwood G. PSA kinetics and PSA bounce following permanent seed prostate brachytherapy. Int J Radiat Oncol Biol Phys 69 (2007) 426-433
8. Ciezki J., Reddy C., Jorge G., Klein E., Angermeier K., Ulchaker J., et al. PSA kinetics following prostate brachytherapy: The PSA bounce phenomenon and it's implications for PSA doubling time. Int J Radiat Oncol Biol Phys 63 (2005) s317 abstract 2149
9. Bostancic C., Merrick G.S., Butler W.M., Wallner K.E., Allen Z., Galbreath R., et al. Isotope and patient age predict for PSA spikes after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1431-1437
10. Horwitz E.M., Levy L.B., Martinez A.A., Potters L., Beyer D.C., Blasko J.C., et al. The post-treatment PSA bounce for prostate cancer patients treated with external beam RT or permanent brachytherapy alone is not biochemically significant: a multi institutional pooled analysis of more than 7500 patients. Int J Radiat Oncol Biol Phys 66 (2006) s205 abstract 1129
11. Stock R.G., Stone N.N., Tabert A., Iannuzzi C., and DeWyngaert J.K. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41 (1998) 101-108
12. Patel C., Elshaikh M.A., Angermeier K., Ulchaker J., Klein E.A., Chehade N., et al. PSA pounce predicts early success in patients with permanent iodine-125 prostate implant. Urology 63 (2004) 110-113
13. Kadoch C., D'Amico A.V., and Matthews H. When prostate brachytherapy fails: a case report and discussion. The Oncologist 10 (2005) 799-805
14. Das P., Chen M., Valentine K., Lopes L., Cormack A.R., Renshaw A.A., et al. Using the magnitude of PSA bounce after MRI-guided prostate brachytherapy to distinguish recurrence, benign precipitating factors, and idiopathic bounce. Int J Radiat Oncol Biol Phys 54 (2002) 698-702
15. Smathers S., Wallner K., Sprouse J., and True L. Temporary PSA rises and repeat prostate biopsies after brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 1207-1211
16. Reed D., Wallner K., Merrick G., Buskirk S., and True L. Clinical correlated to PSA spikes and positive repeat biopsies after prostate brachytherapy. Urology 62 (2003) 683-688
17. Horwitz E.M., Levy L.B., Thames H.D., Kupelian P.A., Martinez A.A., Michalski J.M., et al. Biochemical and clinical significance of the post treatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation alone. Cancer 107 (2006) 1496-1502
18. Hanlon A.L., Pinover D.O., Horwitz E.M., and Hanks G.E. Patterns and fate of PSA bounce following 3D-CRT. Int J Radiat Oncol Biol Phys 50 (2001) 845-849
19. Pickles T. Prostate-specific antigen (PAS) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys 64 (2006) 1355-1359